NU SKIN ENTERPRISES, INC. Revenue
NU SKIN ENTERPRISES, INC. (NUS) reported Revenue of $320.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $320.11M, a 17.10% decline year-over-year.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $320.61M, a 12.04% decline year-over-year.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $370.32M, a 16.89% decline year-over-year.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $364.21M, a 15.33% decline year-over-year.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.49B, a 14.26% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.73B, a 12.04% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.97B, a 11.53% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $2.23B, a 17.44% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $320.11M 10-Q · filed 2026-08-10 | $640.72M 10-Q · filed 2026-08-10 | $1.01B derived: sum of 3 quarters · filed 2026-08-10 | $1.38B derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $320.61M 10-Q · filed 2026-05-08 | $690.93M derived: sum of 2 quarters · filed 2026-05-08 | $1.06B derived: sum of 3 quarters · filed 2026-05-08 | $1.44B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $370.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $734.53M derived: sum of 2 quarters · filed 2026-02-13 | $1.12B derived: sum of 3 quarters · filed 2026-08-10 | $1.49B 10-K · filed 2026-02-13 |
| 2025-09-30 | $364.21M 10-Q · filed 2025-11-07 | $750.35M derived: sum of 2 quarters · filed 2026-08-10 | $1.11B 10-Q · filed 2025-11-07 | $1.56B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $386.14M 10-Q · filed 2026-08-10 | $750.63M 10-Q · filed 2026-08-10 | $1.20B derived: sum of 3 quarters · filed 2026-08-10 | $1.63B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $364.49M 10-Q · filed 2026-05-08 | $810.04M derived: sum of 2 quarters · filed 2026-05-08 | $1.24B derived: sum of 3 quarters · filed 2026-05-08 | $1.68B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $445.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $875.70M derived: sum of 2 quarters · filed 2026-02-13 | $1.31B derived: sum of 3 quarters · filed 2026-02-13 | $1.73B 10-K · filed 2026-02-13 |
| 2024-09-30 | $430.14M 10-Q · filed 2025-11-07 | $869.23M derived: sum of 2 quarters · filed 2025-11-07 | $1.29B 10-Q · filed 2025-11-07 | $1.78B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $439.08M 10-Q · filed 2025-08-08 | $856.39M 10-Q · filed 2025-08-08 | $1.35B derived: sum of 3 quarters · filed 2026-02-13 | $1.84B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $417.31M 10-Q · filed 2025-05-09 | $905.95M derived: sum of 2 quarters · filed 2026-02-13 | $1.40B derived: sum of 3 quarters · filed 2026-02-13 | $1.90B derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $488.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $987.41M derived: sum of 2 quarters · filed 2026-02-13 | $1.49B derived: sum of 3 quarters · filed 2026-02-13 | $1.97B 10-K · filed 2026-02-13 |
| 2023-09-30 | $498.77M 10-Q · filed 2024-11-08 | $999.03M derived: sum of 2 quarters · filed 2024-11-08 | $1.48B 10-Q · filed 2024-11-08 | $2.00B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $500.26M 10-Q · filed 2024-08-09 | $981.72M 10-Q · filed 2024-08-09 | $1.50B derived: sum of 3 quarters · filed 2025-02-14 | $2.04B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $481.46M 10-Q · filed 2024-05-09 | $1.00B derived: sum of 2 quarters · filed 2025-02-14 | $1.54B derived: sum of 3 quarters · filed 2025-02-14 | $2.10B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $522.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $1.06B derived: sum of 2 quarters · filed 2025-02-14 | $1.62B derived: sum of 3 quarters · filed 2025-02-14 | $2.23B 10-K · filed 2025-02-14 |
| 2022-09-30 | $537.80M 10-Q · filed 2023-11-02 | $1.10B derived: sum of 2 quarters · filed 2023-11-02 | $1.70B 10-Q · filed 2023-11-02 | $2.38B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $560.62M 10-Q · filed 2023-08-02 | $1.17B 10-Q · filed 2023-08-02 | $1.84B derived: sum of 3 quarters · filed 2024-02-15 | $2.48B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $604.90M 10-Q · filed 2023-05-04 | $1.28B derived: sum of 2 quarters · filed 2024-02-15 | $1.92B derived: sum of 3 quarters · filed 2024-02-15 | $2.62B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $673.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.31B derived: sum of 2 quarters · filed 2024-02-15 | $2.02B derived: sum of 3 quarters · filed 2024-02-15 | $2.70B 10-K · filed 2024-02-15 |
| 2021-09-30 | $641.15M 10-Q · filed 2022-11-03 | $1.35B derived: sum of 2 quarters · filed 2022-11-03 | $2.02B 10-Q · filed 2022-11-03 | $2.77B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $704.05M 10-Q · filed 2022-08-05 | $1.38B 10-Q · filed 2022-08-05 | $2.13B derived: sum of 3 quarters · filed 2023-02-16 | $2.83B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $677.03M 10-Q · filed 2022-05-05 | $1.43B derived: sum of 2 quarters · filed 2023-02-16 | $2.13B derived: sum of 3 quarters · filed 2023-02-16 | $2.74B derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $748.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.45B derived: sum of 2 quarters · filed 2023-02-16 | $2.06B derived: sum of 3 quarters · filed 2023-02-16 | $2.58B 10-K · filed 2023-02-16 |
| 2020-09-30 | $703.35M 10-Q · filed 2021-11-04 | $1.32B derived: sum of 2 quarters · filed 2021-11-04 | $1.83B 10-Q · filed 2021-11-04 | $2.42B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $612.37M 10-Q · filed 2021-08-05 | $1.13B 10-Q · filed 2021-08-05 | $1.71B derived: sum of 3 quarters · filed 2022-02-16 | $2.30B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $518.03M 10-Q · filed 2021-05-05 | $1.10B derived: sum of 2 quarters · filed 2022-02-16 | $1.69B derived: sum of 3 quarters · filed 2022-02-16 | $2.31B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $583.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.17B derived: sum of 2 quarters · filed 2022-02-16 | $1.80B derived: sum of 3 quarters · filed 2022-02-16 | $2.42B 10-K · filed 2022-02-16 |
| 2019-09-30 | $589.93M 10-Q · filed 2020-11-05 | $1.21B derived: sum of 2 quarters · filed 2020-11-05 | $1.84B 10-Q · filed 2020-11-05 | $2.52B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $623.50M 10-Q · filed 2020-08-06 | $1.25B 10-Q · filed 2020-08-06 | $1.93B derived: sum of 3 quarters · filed 2021-02-11 | $2.61B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $623.62M 10-Q · filed 2020-05-07 | $1.31B derived: sum of 2 quarters · filed 2021-02-11 | $1.98B derived: sum of 3 quarters · filed 2021-02-11 | $2.69B derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $683.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $1.36B derived: sum of 2 quarters · filed 2021-02-11 | $2.06B derived: sum of 3 quarters · filed 2021-02-11 | $2.68B 10-K · filed 2021-02-11 |
| 2018-09-30 | $675.31M 10-Q · filed 2019-11-06 | $1.38B derived: sum of 2 quarters · filed 2019-11-06 | $2.00B 10-Q · filed 2019-11-06 | $2.66B derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $704.19M 10-Q · filed 2019-08-07 | $1.32B 10-Q · filed 2019-08-07 | $1.99B derived: sum of 3 quarters · filed 2020-02-13 | $2.55B derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $616.22M 10-Q · filed 2019-05-01 | $1.28B derived: sum of 2 quarters · filed 2020-02-13 | $1.85B derived: sum of 3 quarters · filed 2020-02-13 | $2.40B derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $666.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $1.23B derived: sum of 2 quarters · filed 2020-02-13 | $1.78B derived: sum of 3 quarters · filed 2020-02-13 | $2.28B 10-K · filed 2020-02-13 |
| 2017-09-30 | $563.70M 10-Q · filed 2018-11-08 | $1.11B derived: sum of 2 quarters · filed 2018-11-08 | $1.61B 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $550.10M 10-Q · filed 2018-08-03 | $1.05B 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $499.10M 10-Q · filed 2018-04-27 | |||
| 2016-12-31 | $2.21B 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |